Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bendectin and birth defects. II: Ecological analyses.

Jeffrey S Kutcher1, Arnold Engle, Jacqueline Firth

  • 1University of Michigan, Department of Neurology, Ann Arbor, Michigan 48109, USA.

Birth Defects Research. Part A, Clinical and Molecular Teratology
|May 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persisting Symptoms after Concussion.

Clinics in sports medicine·2026
Same author

Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated.

Birth defects research·2024
Same author

Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport-Amsterdam, October 2022.

British journal of sports medicine·2023
Same author

Paracetamol use in pregnancy - caution over causal inference from available data.

Nature reviews. Endocrinology·2021
Same author

Aortic Elasticity and Arsenic Exposure: A Step Function rather than a Linear Function.

Risk analysis : an official publication of the Society for Risk Analysis·2021
Same author

A review of low-dose arsenic risks and human cancers.

Toxicology·2021
Same journal

Corrigendum for: Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population, 106:685-695 (10.1002/bdra.23517).

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Response to Dr. Kirby.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Response to letter to the editor by Wise.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Letter to the editor: Comments on venlafaxine paper by Laurent et al.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.

Birth defects research. Part A, Clinical and molecular teratology·2016
Same journal

Evaluation of the Western Australian Register of Developmental Anomalies: Thirty-five years of surveillance.

Birth defects research. Part A, Clinical and molecular teratology·2016
See all related articles

This study found no evidence that Bendectin, a medication for nausea and vomiting of pregnancy (NVP), caused birth defects. Analysis of birth defect rates before and after Bendectin use ceased showed no correlation.

Area of Science:

  • Reproductive Health
  • Teratology
  • Pharmacoepidemiology

Background:

  • Bendectin was a primary treatment for nausea and vomiting of pregnancy (NVP) until the early 1980s.
  • Discontinuation followed allegations of causing birth defects, despite meta-analyses showing no teratogenic effect.
  • This study employed ecological analysis to re-examine the teratogenic hypothesis.

Purpose of the Study:

  • To investigate the potential teratogenic effects of Bendectin using ecological analysis.
  • To compare national birth defect prevalence data with Bendectin sales and NVP hospitalization rates.

Main Methods:

  • Utilized annual birth defect prevalence data (1970s-1990s) from the CDC's Birth Defect Monitoring Program.
  • Compared US birth defect data graphically with annual US Bendectin sales and NVP hospitalization rates.

Related Experiment Videos

  • Conducted temporal comparisons of these three data sets.

    • Main Results:

    • No changes in specific birth defect prevalence rates were observed that correlated with the cessation of Bendectin use in the 1980-84 period.
    • The hospitalization rate for NVP doubled after Bendectin use was discontinued.
    • Ecological analysis results align with individual-level epidemiological findings.

    Conclusions:

    • Ecological analyses complement epidemiological studies, showing no evidence of Bendectin causing birth defects.
    • The findings support the safety of Bendectin regarding teratogenic effects.
    • The rise in NVP hospitalizations post-Bendectin cessation warrants further consideration.